BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 17032410)

  • 1. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
    Parise ER; Oliveira AC; Figueiredo-Mendes C; Lanzoni V; Martins J; Nader H; Ferraz ML
    Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
    Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
    Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the effect of splenectomy on hepatic functional reserve and structural damage in patients with chronic hepatitis C virus infection by non-invasive serum markers. A prospective study.
    Elsebae MM; Abu-Zekri NB
    Int J Surg; 2008 Oct; 6(5):362-6. PubMed ID: 18662898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
    Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
    Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection.
    Pohl A; Behling C; Oliver D; Kilani M; Monson P; Hassanein T
    Am J Gastroenterol; 2001 Nov; 96(11):3142-6. PubMed ID: 11721762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
    Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
    Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
    Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection.
    Schiavon LL; Narciso-Schiavon JL; Carvalho Filho RJ; Sampaio JP; Medina-Pestana JO; Lanzoni VP; Silva AE; Ferraz ML
    J Viral Hepat; 2008 Sep; 15(9):666-74. PubMed ID: 18482283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
    Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
    Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of diagnostic accuracy of APRI for prediction of fibrosis in hepatitis C patients.
    Khan DA; Fatima-Tuz-Zuhra ; Khan FA; Mubarak A
    J Ayub Med Coll Abbottabad; 2008; 20(4):122-6. PubMed ID: 19999223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyaluronic acid and aspartate aminotransferase levels normalized by liver function can reflect sinusoidal impairment in chronic liver disease.
    Testa E; Malfatti F; Milazzo S; Cordiviola C; Cotellessa T; Marabotto E; Giannini E; Ceppa P; Mamone M; Risso D; Testa R
    Liver Int; 2006 May; 26(4):439-44. PubMed ID: 16629647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid, transforming growth factor-beta1 and hepatic fibrosis in patients with chronic hepatitis C virus and human immunodeficiency virus co-infection.
    Sanvisens A; Serra I; Tural C; Tor J; Ojanguren I; Barluenga E; Rey-Joly C; Clotet B; Muga R
    J Viral Hepat; 2009 Jul; 16(7):513-8. PubMed ID: 19200132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
    Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
    Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of a simple model for predicting liver fibrosis in HIV/hepatitis C virus-coinfected patients.
    Al-Mohri H; Cooper C; Murphy T; Klein MB
    HIV Med; 2005 Nov; 6(6):375-8. PubMed ID: 16268817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive models for predicting histology in patients with chronic hepatitis B.
    Wai CT; Cheng CL; Wee A; Dan YY; Chan E; Chua W; Mak B; Oo AM; Lim SG
    Liver Int; 2006 Aug; 26(6):666-72. PubMed ID: 16842322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
    Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
    J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APRI and FIB-4 Scores Are Useful After Liver Transplantation Independently of Etiology.
    Pissaia A; Borderie D; Bernard D; Scatton O; Calmus Y; Conti F
    Transplant Proc; 2009 Mar; 41(2):679-81. PubMed ID: 19328955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective comparison of six non-invasive scores for the diagnosis of liver fibrosis in chronic hepatitis C.
    Leroy V; Hilleret MN; Sturm N; Trocme C; Renversez JC; Faure P; Morel F; Zarski JP
    J Hepatol; 2007 May; 46(5):775-82. PubMed ID: 17321634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of three non-invasive markers in assessing the severity of liver fibrosis in chronic hepatitis C.
    Shaikh S; Memon MS; Ghani H; Baloch GH; Jaffery M; Shaikh K
    J Coll Physicians Surg Pak; 2009 Aug; 19(8):478-82. PubMed ID: 19651008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.